MAIA - MAIA Biotechnology, Inc.

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.53 -0.1 (-6.54%)	---	---	0.0 (-0.13%)	-0.03 (-2.0%)	-0.04 (-2.7%)	-0.01 (-0.69%)	-0.01 (-0.69%)

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.18
Diluted EPS:: -0.18
Basic P/E:: -7.9444
Diluted P/E:: -7.9444
RSI(14) 1m:: 37.93
VWAP:: 1.43
RVol:: 0.6634

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.43 -0.02 (-1.72%)	Oct 15 12:45
1m	Price increase 1m	1.5 +0.02 (+1.69%)	Oct 15 10:04
1m	Price decrease 1m	1.46 -0.02 (-1.35%)	Oct 15 10:02
60m	Price decrease 60m	1.45 -0.08 (-5.05%)	Oct 15 09:49
1m	Price decrease 1m	1.46 -0.02 (-1.05%)	Oct 15 09:42